Clinical Trial: Inotuzumab as Post-Trasplantation Therapy for Adult High-risk B-cell Precursor Acute Lymphoblastic Leukemia

U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07862946) titled 'Inotuzumab as Post-Trasplantation Therapy for Adult High-risk B-cell Precursor Acute Lymphoblastic Leukemia' on Oct. 02.

Brief Summary: The goal of this clinical trial is to learn if Inotuzumab Ozogamicin works to prevent relapses after transplantation in adult high-risk B-cell precursor acute lymphoblastic leukemia treated with the PETHEMA ALL-2025 protocol.

The main questions it aims to answer are:

* Do patients receiving Inotuzumab ozogamicin post-transplantation suffer less relapses than those patients not receiving this therapy (control group) within the ALL-2025 protocol?

* Do patients receiving Inotuzumab ozogamicin show mo...